Europe's COVID-19 Procedures ‘Must Not Be Delayed’
Regulatory Network Needs To Work In Harmony
Executive Summary
The coronavirus could have serious adverse effects on regulatory procedures at both European Medicines Agency and EU member state level. A new business continuity plan describes how procedures will be prioritized if problems arise.